ESC 365 - Professor Colin Baigent

Speaker illustration

Professor Colin Baigent

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Member of:

Professor Colin Baigent FMedSci is Director of the MRC Population Health Research Unit and Deputy Director of the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) at the University of Oxford, where he is Professor of Epidemiology. Professor Baigent’s main scientific interests are in the design and conduct of large-scale randomized trials and the use of meta-analysis to assess the efficacy and safety of drugs for treating or preventing cardiovascular disease. He has a particular interest in the epidemiology of CVD in renal failure, and led the Study of Heart and Renal Protection (SHARP), which showed that lowering LDL cholesterol significantly reduced the risk of atherosclerotic events in patients with chronic kidney disease. His group is now coordinating the EMPA KIDNEY trial of empagliflozin vs placebo in over 6,000 patients with CKD. He was co-chair of the 2019 ESC/EAS lipid guidelines and chair of the ESC Clinical Practice Guidelines Committee (2020-2).

Sessions Presentations Events Articles

Role of lipids in clinical setting

Event: ESC Congress 2022

Topic: Risk Factors and Prevention

Session type: Abstract Sessions

2022 ESC Guidelines overview

Event: ESC Congress 2022

Topic: European Society of Cardiology

Session type: New ESC Guidelines

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session type: New ESC Guidelines

2019 ESC/EAS Guidelines on Dyslipidaemias

Event: ESC Congress 2019

Topic: Lipids

Session type: New ESC Guidelines

Meet the Task Force of the 2019 ESC/EAS Guidelines on Dyslipidaemias

Event: ESC Congress 2019

Topic: Lipids

Session type: Special Session

Professor Braunwald’s perspective on lipid lowering

Event: ESC Congress 2019

Topic: Lipids

Session type: Special Session

Meet the trialist - THEMIS/THEMIS PCI

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session type: Late-Breaking Science

Evidence to inform practice: promising avenues and dead ends

Event: ESC Congress 2018

Topic: e-Cardiology/Digital Health

Session type: Symposium

ESC ATLAS of Cardiology: statistics on cardiovascular disease and care

Event: ESC Congress 2018

Topic: European Society of Cardiology

Session type: Special Session

ESC 365 is supported by